tandutinib   Click here for help

GtoPdb Ligand ID: 5695

Synonyms: CT53518 | MLN-518 | MLN518
Compound class: Synthetic organic
Comment: Tandutinib is reported as a fms-related tyrosine kinase 3 (FLT3) inhibitor, although it has almost identical IC50s for PDGRFβ and KIT [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 79.4
Molecular weight 561.33
XLogP 4.53
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
Isomeric SMILES COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
InChI InChI=1S/C32H43N5O4/c1-24(2)41-26-10-8-25(9-11-26)34-32(38)37-19-17-36(18-20-37)29-12-13-33-28-23-31(30(39-3)22-27(28)29)40-21-7-16-35-14-5-4-6-15-35/h8-13,22-24H,4-7,14-21H2,1-3H3,(H,34,38)
No information available.
Summary of Clinical Use Click here for help
Tandutinib has been investigated in Phase II clinical trials for various types of cancer. Click here to link to ClinicalTrials.gov's full list of Phase II tandutinib trials.